| Filed | Form | Description | |
|---|---|---|---|
| 2/17/26 | PRE 14A | PRE 14A | → |
| 4/22/25 | DEFA14A | DEFA14A | → |
| 4/22/25 | DEF 14A | DEF 14A | → |
| 3/25/25 | PRE 14A | PRE 14A | → |
| 3/26/24 | DEFA14A | DEFA14A | → |
| 3/26/24 | DEF 14A | DEF 14A | → |
| ↓ | |||
| Filed | Form | Description | |
|---|---|---|---|
| 3/3/26 | 4 | PRIMARY DOCUMENT | → |
| 3/3/26 | 4 | PRIMARY DOCUMENT | → |
| 3/3/26 | 4 | PRIMARY DOCUMENT | → |
| 3/3/26 | 4 | PRIMARY DOCUMENT | → |
| 3/3/26 | 4 | PRIMARY DOCUMENT | → |
| 3/3/26 | 4 | PRIMARY DOCUMENT | → |
| ↓ | |||
Lexicon Pharmaceuticals, Inc. is a biopharmaceutical company developing treatments for human disease.